Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if Transcranial Direct Current Stimulation (tDCS) can reduce pain perception associated with the effects of receiving definitive radiation therapy or chemoradiotherapy in head and neck cancer (HNCa) patients.

Clinical Trial Description

The goal of this study is to investigate the effectiveness of tDCS as a novel pain relief modality for odynophagia due to mucositis in patients with locally advanced head and neck cancer undergoing definitive radiation therapy or chemoradiotherapy. Participants will be randomized into one of two arms: (1) Treatment: radiation/chemoradiotherapy standard of care + tDCS neuromodulation or (2) Control: radiation/chemoradiotherapy standard of care only.

Patients in the treatment arm will undergo tDCS stimulation on the day of their radiation/chemoradiotherapy appointments, prior to receiving treatment. This will occur daily (5 days per week) during the second and third weeks of therapy, three times per week during the fourth and fifth weeks, and twice per week during the sixth and seventh weeks.

Patients will also have EEG recordings during the study. This will occur at the pre-study visit, the first stimulation appointment, the third week, the 7th week, and during the follow-up appointments (one-week and one-month). ;

Study Design

Related Conditions & MeSH terms

NCT number NCT02366611
Study type Interventional
Source University of Michigan
Status Active, not recruiting
Phase N/A
Start date November 2014

See also
  Status Clinical Trial Phase
Recruiting NCT03574870 - Wearable Sensor for Biometrics During Locoregional Therapy for Head and Neck Cancer Early Phase 1
Recruiting NCT03419741 - Brain Stimulation For Cancer Smokers N/A
Recruiting NCT02528955 - De-Intensification Radiotherapy Postoperative Head Neck Phase 2
Completed NCT00318890 - Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck Phase 1/Phase 2
Not yet recruiting NCT02557048 - Head and Neck Cancer in Children: A Retrospective Study N/A
Recruiting NCT02869399 - Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention Phase 2
Active, not recruiting NCT02075112 - Soy Isoflavone in Combination With Radiation Therapy and Cisplatin in SCC of the Head and Neck Phase 1
Completed NCT00798655 - Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer Phase 2
Recruiting NCT02900911 - Swallowing Rehabilitation in Patients With Head and Neck Cancer Receiving Radiotherapy N/A
Recruiting NCT02790853 - Multimodal Imaging for Surveillance of Patients With Oral Potentially Malignant Disorders N/A
Completed NCT01317589 - Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective? Phase 4
Recruiting NCT02296684 - Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma Phase 2
Active, not recruiting NCT01116336 - Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck Phase 1
Terminated NCT00200408 - Assessment of Early Genetic Changes in Smokers N/A
Completed NCT02648178 - Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related Cancers N/A
Completed NCT02053428 - Comparison of Percutaneous Image-guided Gastrostomies N/A
Completed NCT01681654 - Exercise and Nutrition for Head and Neck Cancer Patients N/A
Completed NCT01235052 - Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer N/A
Completed NCT00038584 - A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer Phase 1
Recruiting NCT03558594 - Hypnosis and Meditation for Cancer Pain N/A